The use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction: scoping review.
Joana Catarina Costa MartinsAna Rosa Cristão Afonso LucasJoana Margarida Meneses CostaPublished in: Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia (2024)
Overall, the efficacy of sildenafil in the treatment of FSD remains controversial and inconclusive based on the available evidence. Further research is necessary to clarify the therapeutic potential of iPDE5 in addressing FSD and to better understand the factors that influence treatment outcomes.